JP2010533660A5 - - Google Patents

Download PDF

Info

Publication number
JP2010533660A5
JP2010533660A5 JP2010516366A JP2010516366A JP2010533660A5 JP 2010533660 A5 JP2010533660 A5 JP 2010533660A5 JP 2010516366 A JP2010516366 A JP 2010516366A JP 2010516366 A JP2010516366 A JP 2010516366A JP 2010533660 A5 JP2010533660 A5 JP 2010533660A5
Authority
JP
Japan
Prior art keywords
granulin
nucleic acid
pharmaceutical composition
compound
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010516366A
Other languages
English (en)
Japanese (ja)
Other versions
JP5584618B2 (ja
JP2010533660A (ja
Filing date
Publication date
Priority claimed from DE102007033359A external-priority patent/DE102007033359B4/de
Application filed filed Critical
Publication of JP2010533660A publication Critical patent/JP2010533660A/ja
Publication of JP2010533660A5 publication Critical patent/JP2010533660A5/ja
Application granted granted Critical
Publication of JP5584618B2 publication Critical patent/JP5584618B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010516366A 2007-07-16 2008-07-14 慢性疼痛の治療又は予防のためのグラニュリン又はグラニュリン様化合物の使用 Expired - Fee Related JP5584618B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007033359A DE102007033359B4 (de) 2007-07-16 2007-07-16 Verwendung eines Granulins oder einer Granulin-ähnlichen Verbindung zur Therapie oder Prophylaxe von chronischen Schmerzen
DE102007033359.7 2007-07-16
PCT/DE2008/001138 WO2009010045A1 (de) 2007-07-16 2008-07-14 Verwendung eines granulins oder einer granulin-ähnlichen verbindung zur therapie oder prophylaxe von chronischen schmerzen

Publications (3)

Publication Number Publication Date
JP2010533660A JP2010533660A (ja) 2010-10-28
JP2010533660A5 true JP2010533660A5 (enExample) 2012-07-05
JP5584618B2 JP5584618B2 (ja) 2014-09-03

Family

ID=40014940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010516366A Expired - Fee Related JP5584618B2 (ja) 2007-07-16 2008-07-14 慢性疼痛の治療又は予防のためのグラニュリン又はグラニュリン様化合物の使用

Country Status (6)

Country Link
US (2) US8367616B2 (enExample)
EP (1) EP2178553B1 (enExample)
JP (1) JP5584618B2 (enExample)
CA (1) CA2693141C (enExample)
DE (1) DE102007033359B4 (enExample)
WO (1) WO2009010045A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2249861B1 (en) * 2008-01-16 2016-07-06 Neurodyn Life Sciences Inc. Progranulin for use in treating parkinson's disease or alzheimer's disease
US9573972B2 (en) 2008-10-31 2017-02-21 Neurodyn, Inc. Nurotoxic sterol glycosides
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
WO2018013775A2 (en) * 2016-07-14 2018-01-18 Emory University Granulin compositions and uses related thereto
MX2022007486A (es) 2019-12-23 2022-06-29 Denali Therapeutics Inc Variantes de progranulina.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015195A1 (en) * 1992-02-03 1993-08-05 Samuel Solomon Granulins from leukocytes
JP2002335972A (ja) * 2000-06-07 2002-11-26 Ajinomoto Co Inc インスリン受容体関連受容体結合蛋白質及びその利用
US6872703B2 (en) * 2000-06-07 2005-03-29 Ajinomoto Co., Inc. Insulin receptor-related receptor binding protein
DE60334499D1 (de) * 2003-02-26 2010-11-18 A & G Pharmaceuticals Inc Verfahren zur erhöhung der ausbreitung von b-zellen
US8071652B2 (en) * 2003-08-21 2011-12-06 The Board Of Regents Of The University Of Texas System Method of treating irritable bowel syndrome
JP4222614B2 (ja) * 2005-02-10 2009-02-12 独立行政法人科学技術振興機構 神経因性疼痛治療剤
WO2007000924A1 (ja) 2005-06-28 2007-01-04 Osaka University プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法
WO2008019187A2 (en) * 2006-05-30 2008-02-14 Mayo Foundation For Medical Education And Research Detecting and treating dementia

Similar Documents

Publication Publication Date Title
Mwangi et al. Antimicrobial peptides: new hope in the war against multidrug resistance
CA2797437C (en) Peptides and their use as antimicrobial agents
Chong et al. The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders
JP2015517488A5 (enExample)
EP4682148A3 (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
JP2011528713A5 (enExample)
JP2010532761A5 (enExample)
JP2012529293A5 (enExample)
CN102439153A (zh) 用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物
JP2011528333A5 (enExample)
CN102159232A (zh) 使用哺乳动物β防御素治疗炎性疾病
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
WO2013173941A1 (en) Peptide and the use thereof
JP2013504603A5 (enExample)
JP2011528334A5 (enExample)
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases
AU2016281477A1 (en) Broad-spectrum anti-infective peptides
TW200732351A (en) New cyclic peptide compounds
JP2011508727A5 (enExample)
JP2007521333A5 (enExample)
RU2015134356A (ru) Пептид
WO2006105912A3 (en) Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
JP2009507474A5 (enExample)
JP2016160183A5 (ja) 筋萎縮抑制剤及び筋萎縮抑制用飲食品
JP2018512844A5 (enExample)